Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
186 Cards in this Set
- Front
- Back
Non-pharm HF therapy:
*monitor wgt *worsening symptoms/wgt *Na *drugs to avoid bad habits vaccines vitamin wgt management |
*monitor weight qam after voiding, before eating.
*notify provider if sx worsen or if gain 3 or more lbs/day or 5 in a week *limit Na to 2g/day in moderate to severe HF, and to 1500mg if they also have HTN. *avoid NSAID's, including cox2, due to renal insufficiency and fluid retention -ma huang and ephedrine will kill, don't take them -don't smoke, do illegal rx, limit etoh -get flu and pneumo vaccines yearly -keep bmi under 30, exercise 30 min 3-5 d/wk, as tolerated. losing weight makes the heart's job easier. |
|
-anthracyclines esp., traztuzumab, imatinib and docetaxol should be avoided in hf, why?
|
anthracyclines are hard on a healthy heart. traztuzumab, imatinib and docetaxol can cause fluid retention.
|
|
should peeps w/ HF take sympathomimetics or other amphetamines?
|
no
|
|
which CCBs should be avoided in HF?
|
ND-CCB like verapamil and diltiazem can exacerbate HF due to negative inotropic, chronotropic effects.
|
|
avoid which azole in hf? i don't know why
|
itraconazole in HF
|
|
antiarrythmics can worsen HF. which 2 may be lower risk?
|
amiodarone and dofetilide in HF
|
|
which class of antiarrythmics are not to be used in hf?
|
class I antiarrythmics like mexiletine, procainamide, quinidine, disopyramide, tocainamide, flecainamide and propafenone should not be used in HF.
|
|
heart valve disease can be caused
|
fenfluramine, dexfenfluramine, ergot derivatives like ergotamine, dihydroergotamine, methysergide and others in HF.
|
|
some immunmodulators can cause/worsen hf
|
interferons, etanercept (TNF blockers worsen), rituximab in HG
|
|
HF and NSAID's, including COX-2
|
These drugs should be avoided in HF, esp in advanced renal disease. use can worsen renal function, increase fluid retention and worsen hf.
|
|
glucocorticoids
|
steroids that can worsen hf
|
|
Triptans in HF
|
migrane drugs that are CI in cardiovascular disease or uncontrolled htn
|
|
Thiazolidinediones, esp rosiglitazone (Avandia), pioglitazone (Actos) in HF
|
these DM drugs can cause edema, especially if used with insulin
|
|
HF and etoh
|
moderate use may be goodk, but excessive is bad
|
|
2 drug class that should be used in every HF patient w/o a CI
|
acei and bb's
|
|
EF in HF
|
EF less than 40 indicates systolic HF, but EF can be higher in diastolic HF
|
|
BNP (B-type natriuretic peptide) normal range
|
normal range <100pg/ml
|
|
ACC/AHA stage 1
|
patients at risk of HF, but no structural damage or sx's. htn, chd, dm, fatties, metabolic syndrome
|
|
acc/aha stage 2
|
patients have structural damage, but no HF sx's
|
|
ACC/AHA stage of a person with LVH, low EF, MI, valve disease...but no s/s of hf
|
acc/aha stage 2
|
|
acc/aha stage 3
|
someone with known structural heart disease, with prior or current sx's.
|
|
acc/aha stage of a pt with advanced structural disease and sx's at rest despite ma med tx.
|
acc/aha stage 4
|
|
how many acc/aha stages? NYHA classes?
|
4/4
|
|
NYHA class of a pt with no limitations of physical activity. ordinary physical activities do not cause problems
|
nyha class 1
|
|
nyha class of a pt who is comfortable at rest, but ordinary activities cause symptoms
|
nyha class 2
|
|
nyha class of a pt with marked limitations of physical activity. comfortable at rest, but minimal exertion (bathing) brings on sx
|
nyha class 3
|
|
nyha class of a pt who has sx at rest and can not do any physical activity without discomfort.
|
nyha class 4
|
|
*for RAAS inhibitors, to what do you titrate doses?
|
titrate doses to symptoms, not bp with these hf drugs.
|
|
can you do an ace + Arb in HF
|
you could combine these, but watch out for hyperkalemia
|
|
when should you use arb's in hf
|
drug that can be used 1st line, but generally used when pt can tolerate ace
|
|
RAAS inhibitors cause angioedema. who is at higher risk? what drugs are CI if pt develops angioedema?
|
RAAS inhibitors increase risk of this side effect. esp ACEi. blacks are at higher risk. if get angioedema with one, can't use another, I think aliskiren included.
|
|
RAAS inhibitors and KCl
|
HF pts on these drugs should not use salt substitutes (KCl), because it puts them at risk of hyperkalemia. cut down on the Na
|
|
Two reasons captopril (Capoten) is not an ideal acei.
|
This acei has extra side effects (rash, tast perversions) and dosing is more frequent (inconvenient) at bid to tid.
|
|
acei and arbs reduce what loads?
|
both pre and after load are reduced
|
|
acei moa
|
blocks the conversion of at1 to at2 via inhibition of the angiotensin? converting enzyme.
|
|
arb mechanism
|
they block the angiotensin II receptor
|
|
*acei black box
|
pregnacy, stop or don't start
|
|
acei ci's (3)
|
*angioedema
*bilateral renal artery stenosis -use in DM when also on aliskiren |
|
*ACEI S/E 5
|
*Cough
*hyperK *angioedema *hypotension -ARF |
|
*ACEI monitorin-4
|
*BP, K, renal, s/s hf
|
|
acei pg cat
|
HF rx that is cat D
|
|
captopril
|
Capoten
|
|
*enalapril, enalaprilat (inj)
|
*Vasotec
|
|
fosinopril
|
Monopril
|
|
*lisinopril
|
*Zestril, Prinivil
|
|
Quinapril
|
Accupril
|
|
*ramapril
|
Altace*
|
|
trandolapril
|
Mavik
|
|
This acei has to be taken an hour before meals
|
captopril (Capoten)
|
|
candesartan
|
Atacand
|
|
*losartan
|
*Cozaar
|
|
*valsartan
|
*Diovan
|
|
*ARB black box
|
*same as acei, pregnancy
|
|
*ARB 3 CI's
|
same as ACEi
*angioedema *bilateral renal artery stenosis -use in DM with Aliskiren |
|
Aldosterone receptor antagonists moa
|
these drugs inhibit the effects of aldosterone, reducing water and sodium.
|
|
aldosterone receptor antagonist are used in what classes
|
III and IV
|
|
why does spironolactone have more SE's than eplenerone?
|
eplenerone is a selective aldosterone blocker, spironolactone in non-selective and also blocks androgen and progesterone receptors.
|
|
*ARB 3 CI's
|
*angioedema
*bilateral renal artery stenosis -use in dm with aliskiren |
|
*ARB 5 SE's
|
*angioedema
*hyperK *hypotension -HA and dizziness |
|
*ARB monitoring 4
|
*BP
*K *renal *s/s hf |
|
arb pg cat
|
D
|
|
K sparing diuretics used in HF
|
spironolactone, eplenerone
|
|
*spironolactone
|
*Aldactone
|
|
eplenerone
|
Inspra
|
|
This Ksparing diuretic has a black box warning for tumor risk
|
Spironolactone, it should only be used as indicated, and unecessary use should be avoid as it has a black box warning for...?
|
|
2 CI to Ksparing diuretics and one specific to eplenerone
|
-these are contraindicated in crcl<30, hyperK
-use with 3A4 inhibitors |
|
2 warnings for ksparing diuretics with regards to K and renal fx
|
-don't start tx if K is greater than 5
-don't use in women with scr over 2, or men with scr over 2.5 |
|
*ksparing diuretic SE's (2), and those specific to spironolactone
|
*HyperK, increased SCr
*Spironolactone also causes breast tenderness and gynecomastia*, impotence, mentrual problems, impotence, hirsutism |
|
*Ksparing diuretic monitoring 4
|
*BP, renal, K, s/s of HF
|
|
*5 ways to minimize hyperK with ksparing diuretics
|
*CI in crcl less than 30, as risk increases with renal dysfunction
*don't start if if K is over 5 *use low doses, risk higher w/ace and arb *don't use nsaids, not supposed to anyway *counsel pt a/b dehydration (vomit/diarrhea...) |
|
Ksparing pg cat
|
spironolacte is C, eplenerone B
|
|
Lithium + diuretics
|
Lithium should not be used with diuretics as they reduce Li clearance and can cause Li toxicity
|
|
is triple tx with ace, arb, aldosterone antagonist recommended?
|
triple therapy increases the risk of hyperK, so no
|
|
This drug class is use to inhibit the SNS.
|
bb's
|
|
bb's are recommended in classes...
|
II-IV
|
|
start BB's when the patient is...
|
these drugs are started when the pt is euvolemic and asymptomatic, otherwise HF can worsen
|
|
What type of bb's should be avoided in HF
|
bb with intrinsic sympathomimetic activity, they may worsen survival
|
|
ISA BB's (4)
|
CAPP should be avoided in HF
|
|
bisoprolol
|
Zebeta
|
|
*metoprolol succinate, extended release
|
Toprol XL
|
|
*carvediolol
|
*Coreg, Coreg CR
|
|
*3 BB's used in HF
|
*bisoprolol, Toprol XL, Carvedilol
|
|
of the 3 HF bb's, which is a non-selective alpha, beta blocker
|
carvedilol
|
|
which hf bb has shown benefit, but does not have an indication?
|
bisoprolol (Zebeta)
|
|
target dose of this hf bb is 10 qd
|
Zebeta(bisoprolol)
|
|
target dose of this hf bb is 200 qd
|
Toprol XL (metoprolol succinate)
|
|
carvedilol target doses
|
25 BID, or 50 BID if pt >80kg, or 80 mg QD of Coreg CR
|
|
*how should all forms of carvedilol be taken
|
*take this bb with food
|
|
Dosing conversions of Coreg to CR
|
3.125 BID to 10 qd
6.25 BID to 20 qd 12.5 BID to 40 qd 25 BID to 80 qd |
|
BB CI 5
|
-sinus bradycardia
-2/3 degree heartblock w/o pacemaker -cardiogenic shock -sick sinus syndrome -do not start if have active bronchospasm |
|
*4 common BB SE's
|
*bradycardia
*hypotension *fatigue *dizziness |
|
6 less commen bb se
|
-depression
-decrease libido -impotence -hyperglycemia (non-select can reduce insulin) -increase tgs -reduce hdl |
|
*BB monitoring 3
|
*HR, BP, s/s HF
|
|
when do you lower bb dose?
when can it increase? |
-lower dose of these drugs when HR is less than 55
-titrate up q 2 wks as tolerated |
|
4 BB cautions
|
-DM with recurrent hypoclycemia
-asthma -COPD -resting limb ischemia |
|
metoprolol tartrate
|
Lopressor, not recommended in HF
|
|
BB and hypoglycemia
|
BB, mostly the non-selective agents, can cover up the signs of hypoglycemia, exept hunger and sweating
|
|
BB and hypoglyceMICs (insulin, sulfons)
|
BBs can enhance the effects of these DM drugs
|
|
BB's and digoxin
|
both slow HR
|
|
carvedilol metabolism
|
2D6, wathch for interactions
|
|
carvedilol + CSA or digoxin
|
carvedilol can increase the concentrations of csa and dig
|
|
hydralazine is a direct ____ vasodilator which reduces ____ ?
|
arterial, afterload
|
|
Nitrates are ____ vasodilators and reduce ___?
|
venous, preload
|
|
BiDil
|
combination of nitrate and hydralazine
|
|
BiDil indication
|
indicated for use in black patients w/ class III-IV who are symptomatic despite optimal tx w/ acei and bb's.
|
|
why else might you use hydralazine and nitrates?
|
also used in patients who can not tolerate acei, arb due to poor renal fx, angioedema, or hyperkalemia.
|
|
do you use nitrates alone in HF?
|
No. They are used in combo with hydralazine, which improves efficacy and to reduce nitrate tolerance.
|
|
BiDil
|
isosorbide dinitrate/hydralazine
|
|
*any nitrate tolerance with BiDil
|
*No nitrate tolerance with this combo.
|
|
BiDil (20-37.5) target?
|
-Start 1 TID, increase to target of 2 TID, if tolerated.
-in other words 75mg hydralazine/40mg ISDN TID. |
|
*BiDil is CI with what Rx? what component is the problem?
|
*This HF drug is contraindicated for use with PDE-5 drugs due to the nitrate component.
|
|
*among s/e for BiDil are reflex tachy and Lupus like syndrome, what is the cause of this?
|
*Hydralazine can cause these s/e.
|
|
*HA and dizziness from BiDil are due to what component?
|
*The nitrate component in BiDil can cause these S/E.
|
|
*isosorbide mononitrate
|
*Imdur, Monoket
|
|
isosorbide dinitrate
|
Isordil, Dilatrate SR
|
|
*Drug CI with BiDil or any of the nitrates.
|
*PDE5 inhibitors
|
|
*3 things to monitor when using hydralazine, nitrates, BiDil...
|
*HR, BP, s/s HF
|
|
hydralazine target
|
75 QID
|
|
mononitrate is given ___ or ___
|
daily or bid
|
|
dinitrate is given ___ or ___
|
tid or qid
|
|
target dose of hydralazine, not BiDil
|
75 qid
|
|
nitrate target dose, not bidil
|
40 qid
|
|
*ISMN and ISDN can cause HA and dizziness. what other problem is there?
|
*Nitrates, not BiDil, can have tachyphylaxis and need a 10-12 hr nitrate free period.
|
|
What options are there when a diuretic dose becomes ineffective?
|
Increase dose, go IV, go continuous infusion, or add metolazone
|
|
*furosemide
|
*Lasix
|
|
bumetanide
|
?Bumex?
|
|
torsemide
|
Demadex
|
|
ethacrynic acid
|
Edecrin
|
|
*oral loop dose equivalency of furosemide
|
40 mg
|
|
*oral loop dose equivalency of bumetanide
|
1 mg
|
|
*oral loop dose equivalency of torsemide
|
20 mg
|
|
Loop black box
|
profound diuresis and electrolyte depletion is black box warning
|
|
loop CI
|
anuria is a CI to these diuretics
|
|
*what electrolytes are affected by loops
|
these diuretics reduce K, Ca, Mg, Cl, and Na
|
|
*other than problems with electrolytes, loops have these side effects (6)
|
Side effects from this drugs include:
*orthostatic hypotension *metabolic alkylosis *hyperuricemia *hyperglycemia *photosensitivity *ototoxicity (more w/ethacrynic acid) |
|
*5 things to monitor when using loops
|
when using this rx, monitor:
*renal *fluid status *BP *electrolytes *hearing w/high dose or rapid IV |
|
IV loop storage
|
IV forms of these drugs should be stored in amber bottles
|
|
furosemide IV:PO ratio
|
IV:PO ratio of this drug is 2:1
|
|
what allergy is a concern with using loops? with the exception of___
|
sulfa, ethacrynic acid
|
|
loop pg cat
|
B for ethacrynic acid and torsemide
C for furosemide and bumetanide |
|
Only use loops in combo with these drugs in life threatening situations due to ototoxicity
|
Aminoglycosides should not be used with loops due to this s/e. Risk is greater w/ reduced renal fx.
|
|
Li +diuretics
|
diuretics should not be used with this drug as they will decrease its clearance and lead to toxicity
|
|
nsaids should not be used in HF anyway, but what problem do they cause w/loops.
|
these drugs cause NA and water retention and reduce the effect of loops.
|
|
digoxin MOA
|
this drug inhibits a Na/K ATPase pump, acts as a positive inotrope and negative chronotrope
|
|
*digoxin
|
*Lanoxin
|
|
*digoxin dose is based on...
|
*renal function and current meds
|
|
most patients take this dose of digoxin
|
0.125 mg qd
|
|
do you use a LD of digoxin in HF?
|
no LD for dig in HF.
|
|
*digoxin therapeutic range in HF
|
*0.5-0.9 ng/ml is the therapeutic range for this drug in hf
|
|
digoxin CI (2)
|
2/3 degree heart block without a pacemaker, Wolf-Parkinson White syndrome with AFib are CI's
|
|
digoxin s/e (7)
|
dizzy, HA
diarrhea, n/v, anorexia mental changes |
|
dig monitoring 5
|
HR, BP, electrolytes (K, Ca, Mg), renal, ECG if suspect toxicity
|
|
when do you lower dig dose?
|
when CrCl is less than 50, reduce the dose of this rx
|
|
if you need to lower dig dose...
|
can do 0.125 qod or less frequently
|
|
*s/s of digoxin toxicity...starts with...
|
*-toxicity starts with n/v and loss of appetite and bradycardia.
-vision problems like halos, blurred/double vision, color perception, confusion, ab pain -confusion, delirium, -prolonged PR, accelerated junctional rhythm, bidirectional v. tachycardia |
|
dig pg cat
|
c
|
|
*antidote for dig tox
|
*Digifab or digibind are antidotes
|
|
2 other drugs that reduce HR w/ dig
|
BB's and non-DHP CB
|
|
dig and renal fx
|
it is mostly cleared by kidneys, partly by liver. may need to reduce dose if reduce renal function, or hold dose if ARF.
|
|
being a 3A4 substrate digoxin can increase if used with ___, requiring a dose reduction
|
amiodarone, quinidine, verapamil, erythromycin, clarithromycin, azoles anntifungals, CSA, propafenone, PI's
|
|
2 drugs listed that may decrease dig levels
|
BAS and St. John's wort could reduce conentrations
|
|
how do levels of K and Ca affect dig toxicity risk
|
HypoK (less than 3.5) can increase risk of toxicity as can hypercalcemia
|
|
BNP, pro-BNP indicate...
|
indicators of HF exacerabtion, important so that you can rule out other causes of sx, like copd
|
|
If the loop becomes ineffective and you and metolazone, when do you give it.
|
Give metolazone 30 min before the loop. i think this allows the metolazone to get to distal tubules
|
|
if not hypotensive, adhf sx can be treated with
|
Vasodilators like NG, NP, or nesiritide
|
|
If a pt with adhf is hyptensive (sbp less than 90 or has sx's), these could be used to help with CO
|
IV inotropic drugs like dobutamine, or milrinone
|
|
nesiritide moa
|
it is a b-type natriuretic peptide that binds smooth muscle, increases cGMP leading to relaxation of vascular, blah, blah
|
|
nesiritide tachyphylaxis
|
no tachyphylaxis with this vasodilator
|
|
Concern of increased death and worsening renal with nesiritide?
|
ascend-hf trial showed that conclusions of 2 prior meta analysis of nesiritide were incorrect
|
|
NG mostly dilates
|
veins
|
|
NP dilates...
|
arterial and venous dilation, and has a more pronounced effect on BP
|
|
*nesiritide
|
*Natrecor
|
|
*nitroprusside
|
*Nitropress
|
|
*of nesiritide, ng, np...
-all 3 are CI if___. Both___ and___ are CI with use of____ and in cases of ____. |
*All 3 are CI if sbp is less than 90
*NG and NP are CI with use of PDE5 inhibitors and in cases of increased intracranial pressure. |
|
*2 main se's from nesiritide
|
*hypotension and increased scr*
|
|
*hypotension, ha, tachycardia are se's of these 2 vasodilators used in HF
|
*NP, NG
|
|
*this vasodilator has a se of tachyphylaxis
|
*NG
|
|
*a side effect specific to NP, risk is increased in renal dysfunction
|
*cyanide/thiocyanate toxicity*
|
|
*VDilator monitoring
|
*for all 3, monitor BP, renal, urine output
*monitor HR for NG and NP * watch for CN toxicity w/ NP, as well as acid/base status |
|
*how should NP infusion bag be treated?
*when can you not use it? |
*infusion bag of this drug should be covered w/ an opaque material or aluminum foil.
*if it is blue, you have CN, don't use it |
|
why is NG given continuous infusion
|
due to short t1/2
|
|
storage of IV NG
|
store this iv drug in polyolefin (PAB or EXCEL) as adsorption can occur if use soft plastic (pvc)
|
|
2mcg/kg bolus followed by 0.01mcg/kg/min X48hrs
|
dosing for nesiritide (Natrecor)
|
|
why is coreg taken cf?
|
to slow adsorption and reduce dizziness, this med is taken cf in all forms.
|
|
what if they can't swallow coreg cr caps?
|
they can open and sprinkle them on applesause, and only applesauce, and only cold applesauce, not warm. and they need to eat it right away
|
|
these drugs can increase pain from PVD like pain, numb, cold
|
BB's
|